NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Spectral AI, Inc. (MDAI) Stock Analysis

Spectral AI, Inc. (MDAI) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

MDAI

$1.57

+$0.01 (+0.64%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MDAI with… →

MDAI Key Statistics

As of Sep 4, 2026
Trading
Open
$1.56
Previous Close
$1.56
Day's Range
1.56–1.59
52-Week Range
1.18–2.97
Volume
82.20K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.18
Valuation
Market Cap
$50.53M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.28
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.32
Financials (FY)
Revenue (FY)
$19.65M−33.57%
Net Income (FY)
−$7.57M
Profit marginThe share of revenue left as profit after all costs and taxes.
−65.54%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
32.18M
1-Year Return
−14.21%
Dividend and dates
Earnings Date
November 10, 2026
Avg Volume
212.60K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MDAI Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+10.56%
2025−49.82%
2024+15.04%
2023−75.64%
2022+2.96%
2021 (partial year)+1.13%

As of September 4, 2026.

MDAI Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$19.65M−$7.57M−38.5%
2024$29.58M−$15.16M−51.2%
2023$18.06M−$20.85M−115.5%
2022$25.37M−$2.91M−11.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$19.65M$8.93M−$8.60M−$7.57M−38.5%
2024$29.58M$13.27M−$6.58M−$15.16M−51.2%
2023$18.06M$7.88M−$12.98M−$20.85M−115.5%
2022$25.37M$10.84M−$2.65M−$2.91M−11.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MDAI Valuation vs Medical Devices Median

Median of 151 stocks
MetricMDAIMedical Devices medianvs median
P/S ratio3.282.9810% above
Profit margin−65.54%−1.69%63.8 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Spectral AI, Inc. (MDAI) at $50.53M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 65 employees.

Over the past 52 weeks the price has ranged from $1.18 to $2.97. The most recent close on file for MDAI is $1.57, dated September 4, 2026. That is +$0.01 (+0.64%) against the previous close. The latest close sits 33.05% above that 52-week low.

Financial Health

In fiscal 2025, Spectral AI, Inc. reported revenue of $19.65M. Against the prior fiscal year total of $29.58M, that is a change of −33.57%. The same year closed with a net loss of $7.57M. The reported profit margin is −65.54%. That is 63.8 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −0.32.

Across the 4 fiscal years on file, revenue moves from $25.37M in 2022 to $19.65M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 3.28 times revenue. On price-to-sales that is 10.3% above the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −14.21%. Across 5 years the annualized return works out at −30.53%. Beta against the wider market is reported at 1.18. Annualized volatility over the trailing 5 years is 83.16%.

Growth & Income

No dividend is on file for MDAI.

So far in 2026 the price is +10.56%. Across the complete calendar years on file, 2024 returned +15.04% and 2023 returned −75.64%. Of the 4 complete calendar years on file, 2 finished higher.

Peer Comparison

Spectral AI, Inc. (MDAI) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Spectral AI, Inc. MDAI $50.53M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Spectral AI, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Spectral AI, Inc.

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images. Spectral AI, Inc. is headquartered in Dallas, Texas.

Visit website →